AHCC Events

Event list

Browse past and upcoming AHCC Trials Group events, including symposia and investigator meetings on liver cancer research.

AHCC Trials Group 7th Symposium of the Singapore Liver Cancer Consortium (SLCC) – 21 August 2025

Explore the latest research and clinical advances at the 7th SLCC Scientific Symposium 2025.

AHCC Trials Group 6th Symposium of the Singapore Liver Cancer Consortium (SLCC) – 25 July 2024

Explore the latest developments in cancer care at the 6th SLCC Scientific Symposium, bringing together experts to advance research and clinical practice.

AHCC Trials Group 5th Symposium of the Singapore Liver Cancer Consortium (SLCC) – 1 June 2023

Explore the latest research and clinical advancements at the 5th SLCC Scientific Symposium.

AHCC Trials Group 4th Symposium of the Singapore Liver Cancer Consortium (SLCC) – 26 March 2022

Explore highlights from the AHCC 4th Symposium, showcasing the latest developments and research in the field.

AHCC Trials Group 3rd Symposium of the Singapore Liver Cancer Consortium (SLCC) – 3 May 2019

Explore the programme for the AHCC 3rd SLCC Symposium and find out what's in store for attendees.

AHCC06 Result Presentation

Find out the final results of the AHCC06 trial, comparing two treatments for liver cancer, presented at the 2017 ASCO Annual Meeting in Chicago.

Asia Pacific Hepatocellular Carcinoma (AHCC) Trials Group Scientific Forum and General Meeting

Read about the highlights from the AHCC Trials Group's first Scientific Forum and 6th General Meeting, held in Singapore in October 2014.

AHCC06 2nd Interim Analysis 2014

The AHCC06 (SIRveNIB) trial's second Interim Analysis confirmed good trial conduct, solid data, and strong safety outcomes. Read on for details from the Data Safety and Monitoring Board's review.

AHCC06 1st Interim Analysis 2013

Read about the key findings of this meeting and what this milestone means for the SGH-led multi-centre liver cancer trial.

AHCC06 Investigator Meeting 2012

Investigators from across Asia-Pacific and Europe gathered in Singapore for the AHCC06 Trial's second meeting. Key updates on trial progress, recruitment strategies, and ancillary studies were shared.

AHCC06 Investigator Meeting

Investigators from six Asian countries met to discuss protocol updates and share insights on the AHCC06 Trial. Read on to learn about the key outcomes of this collaborative meeting.

Press Conference at National Cancer Centre Singapore: Announcing the Launch of AHCC06 Trial

The AHCC06 trial compares two treatments for advanced liver cancer across 12 countries. Find out how this $10 million study aims to identify the best first-line therapy for patients.

Singapore General Hospital and Sirtex Medical Limited Signs Sponsorship Agreement for AHCC06 Trial

SGH and Sirtex Medical have signed a sponsorship agreement to fund a major phase III trial studying treatments for advanced liver cancer across 13 countries.

5th AHCC Trials Group General Meeting 2010

Read about the highlights of the 5th AHCC Trials Group General Meeting, held at Duke-NUS Graduate Medical School Singapore in February 2010.